# EpiCor (Saccharomyces cerevisiae)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/epicor
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Saccharomyces cerevisiae fermentate, Baker's yeast fermentate, Brewer's yeast fermentate, Yeast postbiotic, S. cerevisiae postbiotic, Dried yeast fermentate, Inactivated yeast complex

## Overview

EpiCor is a standardized fermented yeast extract from Saccharomyces cerevisiae containing [beta-glucan](/ingredients/condition/immune-support)s, mannan oligosaccharides, and amino acids that modulate immune cell activity. It enhances mucosal immunity by increasing secretory IgA production and reducing [inflammatory](/ingredients/condition/inflammation) cytokines.

## Health Benefits

• Supports mucosal immune defense and reduces cold/flu-like symptoms (moderate evidence from 90-day RCT, n=32) • Increases secretory IgA levels in saliva for enhanced [immune function](/ingredients/condition/immune-support) (moderate evidence from controlled trial) • Demonstrates [anti-inflammatory](/ingredients/condition/inflammation) effects by inhibiting TNF-α, IL-1β, IL-6, and IL-8 cytokines (preliminary in vitro evidence) • Reduces skin inflammation markers when applied topically (preliminary evidence from small human trial, n=10) • May support [gut microbiome](/ingredients/condition/gut-health) balance as a postbiotic compound (theoretical based on mechanism)

## Mechanism of Action

EpiCor's [beta-glucan](/ingredients/condition/immune-support)s bind to dectin-1 receptors on immune cells, activating macrophages and dendritic cells to enhance innate immune responses. The mannan oligosaccharides stimulate secretory IgA production in mucosal tissues, while metabolites inhibit [pro-inflammatory cytokine](/ingredients/condition/inflammation)s TNF-α, IL-1β, and IL-6. This dual action supports both immediate immune defense and reduces excessive inflammatory responses.

## Clinical Summary

A 90-day randomized controlled trial (n=32) demonstrated that EpiCor supplementation significantly reduced cold and flu-like symptoms compared to placebo. Controlled studies show increased salivary secretory IgA levels, indicating enhanced mucosal [immune function](/ingredients/condition/immune-support). Additional research confirms [anti-inflammatory](/ingredients/condition/inflammation) effects through reduced cytokine production. While evidence is promising, larger clinical trials are needed to establish optimal dosing protocols.

## Nutritional Profile

EpiCor is a whole food fermentate derived from Saccharomyces cerevisiae (baker's yeast) produced via a proprietary high-temperature fermentation and drying process. Approximate composition per typical 500mg serving: Protein ~25-35% by dry weight (primarily yeast-derived peptides and mannoproteins); Carbohydrates ~40-50% by dry weight including beta-1,3/1,6-glucans (~10-15%), mannan oligosaccharides, and dietary fiber (~8-12%); Fat ~5-8% by dry weight including phospholipids and fatty acids. Key bioactive compounds include: polyphenols and [antioxidant](/ingredients/condition/antioxidant)s (~5-8% by dry weight, measured via ORAC assay showing ~3,500-4,500 µmol TE/g); nucleotides and nucleosides derived from yeast RNA; ergosterol (provitamin D2 precursor, ~0.5-1% by dry weight); B-vitamins including thiamine (B1 ~0.3-0.5 mg/100g), riboflavin (B2 ~3-5 mg/100g), niacin (B3 ~30-40 mg/100g), pantothenic acid (B5 ~10-15 mg/100g), and folate (~1-2 mg/100g); minerals including zinc (~3-5 mg/100g), selenium (~0.05-0.1 mg/100g), chromium (~0.1 mg/100g), and iron (~2-4 mg/100g); [glutathione](/ingredients/condition/detox) as a key antioxidant peptide (~0.1-0.5% by dry weight); arabinoxylan-related polysaccharides; and heat-stable metabolites produced during fermentation including organic acids and short-chain fatty acid precursors. Bioavailability note: The fermentation process pre-digests many yeast cell wall components, improving bioavailability of [beta-glucan](/ingredients/condition/immune-support)s and polyphenols compared to raw yeast; beta-glucans are recognized by Dectin-1 and TLR2 receptors in gut-associated lymphoid tissue. The product is standardized to consistent antioxidant and immune-modulating activity rather than a single isolated compound.

## Dosage & Preparation

The clinically studied dose is 500 mg/day of EpiCor powder taken orally, as tested in a 90-day mucosal defense trial. For topical applications, 0.5 g powder reconstituted in 5 mL saline (100 mg/mL) was used in [anti-inflammatory](/ingredients/condition/inflammation) testing. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

EpiCor is generally well-tolerated with minimal reported side effects in clinical studies. Individuals with severe yeast allergies should exercise caution due to its Saccharomyces cerevisiae origin. No significant drug interactions have been documented, though immune-modulating effects may theoretically interact with immunosuppressive medications. Safety during pregnancy and lactation has not been established through clinical research.

## Scientific Research

Clinical evidence for EpiCor includes a randomized, double-blind, placebo-controlled trial (n=32) showing reduced cold/flu symptoms and increased salivary IgA after 90 days of supplementation. [Anti-inflammatory](/ingredients/condition/inflammation) effects were demonstrated in vitro and in a small human skin test (n=10), though no PubMed PMIDs were identified in the available research for EpiCor-specific studies.

## Historical & Cultural Context

EpiCor has no traditional medicinal history as it is a modern, branded product developed through patented fermentation processes. While Saccharomyces cerevisiae has been used for millennia in bread and beer production, EpiCor's postbiotic form is a contemporary innovation without ties to traditional medicine systems.

## Synergistic Combinations

Vitamin C, Zinc, Elderberry, [Probiotic](/ingredients/condition/gut-health)s, [Beta-glucan](/ingredients/condition/immune-support)s

## Frequently Asked Questions

### What is the recommended dosage of EpiCor?

Clinical studies typically used 500mg daily of EpiCor. Most commercial supplements provide this standardized dose, taken once daily with or without food for immune support.

### How long does it take for EpiCor to work?

Initial immune marker changes like increased secretory IgA may occur within 2-4 weeks. However, the 90-day clinical trial suggests optimal benefits for reducing cold/flu symptoms develop over 2-3 months of consistent use.

### Can EpiCor cause yeast infections?

EpiCor is unlikely to cause yeast infections as it contains inactivated Saccharomyces cerevisiae, not live pathogenic Candida species. The fermentation process creates beneficial metabolites rather than active yeast organisms.

### Is EpiCor safe to take with other supplements?

EpiCor appears safe to combine with most dietary supplements including vitamins, minerals, and probiotics. However, those taking immunosuppressive medications should consult healthcare providers before combining immune-modulating supplements.

### What makes EpiCor different from regular yeast supplements?

EpiCor undergoes a proprietary fermentation process that creates unique metabolites, beta-glucans, and amino acids not found in standard yeast. This specific fermentation profile provides the clinically-studied immune benefits rather than just basic nutritional yeast compounds.

### What does the clinical research show about EpiCor's effectiveness for immune support?

EpiCor has moderate evidence from a 90-day randomized controlled trial (n=32) demonstrating reduced cold and flu-like symptoms in users. Additional controlled trials show it increases secretory IgA levels in saliva, which is a key marker of mucosal immune defense. While in vitro studies suggest anti-inflammatory effects through cytokine inhibition (TNF-α, IL-6, IL-8, IL-1β), larger human studies would strengthen the evidence base for these mechanisms.

### Is EpiCor safe for children and elderly individuals?

EpiCor is a fermented Saccharomyces cerevisiae product generally recognized as safe, but specific safety data for children and elderly populations is limited in published literature. Because it's derived from baker's yeast, it should be appropriate for most age groups, though individual tolerance may vary. Consult a healthcare provider before giving EpiCor to very young children or for use in elderly individuals with compromised immune systems or specific health conditions.

### Does EpiCor interact with common immune-boosting medications or immunosuppressants?

Direct drug interaction studies with EpiCor are limited, but its immune-modulating properties suggest potential interactions with immunosuppressive medications (such as corticosteroids or biologics used for autoimmune conditions). Individuals taking prescription immune-modulatory drugs should consult their healthcare provider before supplementing with EpiCor to avoid counteracting intended therapeutic effects. No significant interactions with common over-the-counter supplements have been documented.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*